Compound information
- Natural Products
- ZC1725732
- Molecular Formula
- C18H22N2O2
- Molecular Weight
- 298.168127944 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-(2-naphthylmethyl)piperazine-1-carboxylate
- InChI
- InChI=1S/C18H22N2O2/c1-2-22-18(21)20-11-9-19(10-12-20)14-15-7-8-16-5-3-4-6-17(16)13-15/h3-8,13H,2,9-12,14H2,1H3
- InChI Key
- XFPKYFMNRUXDOP-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(Cc2ccc3ccccc3c2)CC1
- Source
- ZINC000019632724
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 3 |
Heteroatom Count | 4 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 32.78 Å2 | LogP | 3.503 |
LogS | -3.698 | LogD | 3.771 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.604 | Pgp substrate | 0.023 |
HIA | 0.966 | F20 % | 0.955 |
F30 % | 0.844 | Caco-2 | -4.387 |
MDCK | -4.569 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.867 | PPB | 88.054 |
VD | 2.702 | Fu | 0.959 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.039 | CYP1A2 substrate | 0.791 |
CYP2A6 substrate | 0.84 | CYP2B6 substrate | 0.808 |
CYP2C19 inhibitor | 0.754 | CYP2C19 substrate | 0.843 |
CYP2C8 substrate | 0.769 | CYP2C9 inhibitor | 0.465 |
CYP2C9 substrate | 0.63 | CYP2D6 inhibitor | 0.825 |
CYP2D6 substrate | 0.997 | CYP2E1 substrate | 0.88 |
CYP3A4 inhibitor | 0.033 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.32 | CL | 6.659 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.86 | Hepatotoxicity | 0.175 |
Mutagenicity | 0.173 | Rat Oral Acute Toxicity | 0.747 |
FDAMDD | 0.122 | Skin Sensitization | 0.299 |
Carcinogenicity | 0.444 | Eye Corrosion | 0.001 |
Eye Irritation | 0.013 | Respiratory Toxicity | 0.882 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.026 | IGC50 | 3.86 |
LC50FM | 3.768 | LC50DM | -0.934 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.571 | NR-AR-LBD | 0.254 |
NR-AhR | 0.312 | NR-Aromatase | 0.017 |
NR-ER | 0.331 | NR-ER-LBD | 0.368 |
NR-PPAR-gamma | 0.16 | SR-ARE | 0.811 |
SR-ATAD5 | 0.302 | SR-HSE | 0.187 |
SR-MMP | 0.009 | SR-p53 | 0.064 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.